Anti-tumor activity of Phyllanthus niruri (a medicinal plant) on chemical-induced skin carcinogenesis in mice

Asian Pacific Journal of Cancer Prevention

Volumn 10, Issue 6, 2009, Pages 1089-1094

  Sharma, Priyanka ^a,a   Parmar, Jyoti ^a   Verma, Preeti ^a   Goyal, PK ^a  

^a UNIVERSITY OF RAJASTHAN   (India)

Author keywords

Average latent period; DMBA skin carcinogenesis; Phyllanthus niruri; Tumor incidence burden

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; CROTON OIL; PLANT EXTRACT;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CHEMOPROPHYLAXIS; MALE; MOUSE; PAPILLOMA; PHYLLANTHUS; PHYTOTHERAPY; SKIN TUMOR; TOPICAL DRUG ADMINISTRATION;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ADMINISTRATION, TOPICAL; ANIMALS; CHEMOPREVENTION; CROTON OIL; MALE; MICE; PAPILLOMA; PHYLLANTHUS; PHYTOTHERAPY; PLANT EXTRACTS; SKIN NEOPLASMS;

EID: 77956627422     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Azuine MA (1998). Hypothesis: transplacental chemoprevention of cancer. J Transfigural Math, 4, 59-68.
2. Calixton JB, Santos AR, Cechinel FV (1998). A review of the plants of the genus Phyllanthus. Their chemistry, pharmacology and therapeutic potential. Med Res Rev, 18, 251-8.
3. Campos AH, Schor, Nephron N (1999). 81, 393-397.
4. Chung KT, Wong TY, Wei CI (1998). Tannins and human health. Crit Rev Food Sci Nutr, 38, 421-64.
5. Cragg GM, Boyd MR, Cardellina JH, et al (1994). Ethnobotany and drug discovery experience of the US National Cancer Institute. In: Chadwick D.J., Marsh J. (Eds.), Ciba Foundation "Ethnobotany and the search for new drugs" Symposium, 185. Wiley and Sons, Chichester, UK, 178-196.
6. Cragg GM, Newman DJ (2000). Antineoplastic agents from natural sources: achievements and future directions. Expert Opinion on Investigational Drugs, 9, 1-15.
7. Cragg GM, Schepartz SA, Suffness M, Grever MR (1993). The taxol supply crisis. New NCI policies for handling the largescale production of novel natural product anticancer and anti-HIV agents. J Nat Prod, 56, 1657-68.
8. Das M, Ansari KM, Dhawan A, Shukla Y, Khanna SK (2005).Correlation of DNA damage in epidemic dropsy patients to carcinogenic potential of argemone oil and isolated sanguinarine alkaloid in mice. Int J Cancer, 117, 709-717.
9. Deschner EE, Ruperto JF, Wong G, Newmark HL (1991). The Effect of dietary quercetin and rutin on AOM-induced acute colonic epithelial abnormalities in mice fed a high-fat diet. Nutr Cancer, 20, 199-204.
10. DiGiovanni J (1992). Multistage carcinogenesis in mouse skin. Pharmacol Ther, 54, 63-128.
11. Einspahr JG, Stratton SP, Bowden GT, Alberts DS (2002). Chemoprevention of human skin cancer. Crit Rev Oncol Hematol, 41, 269-85.
12. Foo LY (1993). Amariin, a di-dehydro hexahydroxy diphenoyl hydrolysable tannin from Phyllanthus amarus. Phytochemistry, 33, 487-91.
13. Foo LY (1995). Amarinic acid and related ellagitannins from Phyllanthus amarus. Phytochemistry, 39, 217-24.
14. Foo LY, Wong H (1992). Phyllanthisiin, an unusual hydrolysable tannins from Phyllanthus amarus. Phytochemistry, 31, 711-3.
15. Freitas AM, Schor N, Bomi MAB (2002). The effect of Phyllanthus niruri on urinary inhibitors of calcium oxalate crystallization and other factors associated with renal stone formation. BJU Int, 89, 829-34.
16. Gowrishankar B, Vivekanandan OH, (1994). In vivo studies of crude extract of Phyllanthus amarus L by tannery effluents. Mutat Res, 322, 185-92.
17. Halliwell B (1994). Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet, 344, 721-4.
18. Haslam E (1996). Natural polyphenols (vegetable tannins) as drugs: possible mode of action. J Nat Prod, 59, 205-15.
19. Hopkins KM, Auerbach W, Wang XY, et al (2004). Deletion of mouse rad9 causes abnormal cellular responses to DNA damage, genomic instability, and embryonic lethality. Mol Cell Biol, 24, 7235-48.
20. Hu R, Kong AN (2004). Activation of MAP kinases, apoptosis and nutrigenomics of gene expression elicited by dietary cancerprevention compounds. Nutrition, 20, 83-8.
21. Jacks T, Weinberg RA (2002). Taking the study of cancer cell survival to a new dimension. Cell, 111, 923-92.
22. Javed S, Mehrotra NK, Shukla Y (1998). Chemopreventive effects of black tea polyphenols in mouse skin model of carcinogenesis. Biomed Environ Sci, 11, 307-13.
23. Jeena KJ, Joy KL, Kuttan R (1999). Effect of Emblica officinalis, Phyllanthus amarus and Picrorrhiza kurroa on nitrosodiethylamine induced hepatocarcinogenesis. Cancer Lett, 136, 11-6.
24. Jemal A, Murray T, Samuels A, et al (2003). Cancer statistics. CA Cancer J Clin, 53, 5-26.
25. Joy KL, Kuttan R (1995). Antioxidant activity of selected plant extracts. Amala Res Bull, 15, 68-71.
26. Kandaswami C, Middleton E (1994). Free radical scavenging and antioxidant activity of plant flavonoids. Adv Exp Med Biol, 366, 351-76.
27. Kapadia GJ, Azuine MA, Takayasu J, et al (2000). Inhibition of Epstein-Barr virus early antigen activation promoted by 12-O-tetradecanoylphorbol-13-acetate by the non-steroidal antiinflammatory drugs. Cancer Lett, 161, 221-9.
28. Kellof GJ (2000). Perspectives on cancer chemoprevention research and drug development. Adv Cancer Res, 78, 199-334.
29. McCormick DL, Moon RC (1986). Antipromotional activity of dietary N-(4-hydroxyphenyl) retinamide in two-stage skin tumourigenesis in CD-1 and SENCAR mice. Cancer Lett, 31, 133-8.
30. Medicinal Herb Index in Indonesia. (1995). 2nd ed.; PT Eisei Indonesia: Jakarta, p 99.
31. Mehrotra R, Rawat S, Kulshreshtha DK, Patnaik GK, Dhawan BN (1990). In vitro studies on the effect of certain natural products against hepatitis B virus. Ind J Med Res, 92, 133-8.
32. Migliore L, Coppede F (2002). Genetic and environmental factors in cancer and neurodegenerative diseases. Mutat Res, 512, 135-53.
33. Nagasaki Y, Nakamura K (1998). Modulation of the heat-induced activation of mitogen-activated protein (MAP) kinase by quercetin. Biochem Pharmacol, 56, 1151-5.
34. Naik AD, Juvekar AR (2003). Effects of alkaloidal extract of Phyllanthus niruri on HIV replication. Ind J Med Sci, 57, 387-93.
35. Nara TK, Glyeye J, Cerval EL, Stanislan E (1977). Flavonoids of Phyllanthus niruri, Phyllanthus urinaria, Phyllanthus orbiculatus. Plantes Med Phytotherapie, 11, 82-6.
36. Nishino H, Iwashima A, Fujiki H, Sugimura T (1984). Inhibition by quercetin of the promoting dffect of telecidine on skin papilloma formation in mice intiated with 7,12-dimethylbenz(a)anthracene. Gann, 75, 113-6.
37. Noonberge SB, Benz C (2000). Tyrisine kinase inhibitors targated to the epidermal growth factor receptor subfamily. Role as anticancer agents. Drugs, 59, 753-67.
38. Ogata T, Higuchi H, Mochida S, Matsumoto H, Kato A (1992). HIV-1 reverse transcriptase inhibitor from Phyllanthrus niruri. Aids Res Hum Retroviruses, 8, 1937-44.
39. Polya GM, Wang BH, Fooly LY (1995). Inhibition of signal regulated protein kinases by plant derived hydrolysable tannins. Phytochemistry, 38, 307-14.
40. Rajeshkumar NV, Kuttan R (2000). Phyllanthus amarus extract administration increases the life span of rats with hepatocellular carcinoma. J Ethnopharmacol, 73, 215-9.
41. Singh K, Khanna AK, Chander R (1999). Protective effect of ellagic acid on t-butyl hydroperoxide induced lipid peroxidation in isolated rat hepatocytes, Ind J Exp Biol, 37, 939-43.
42. Somanabandhu A, Nityangkuru S, Mahidol C (1993). 1H and 13C NMR assignments of phyllanthin and hypophyllanthin lignans that enhance cytotoxic responses with cultured multidrug-resistant cells. J Nat Prod, 56, 233-9.
43. Sporn MB (1976). Approaches to prevention of epithelial cancer during the preneoplastic period. Cancer Res, 36, 2699-702.
44. Sporn MB, Suh N (2000). Chemoprevention of cancer. Carcinogenesis, 21, 525-30.
45. Tanaka T, Kawabata K, Honjo S, et al (1999). Inhibition of azoxymethane-induced aberrant crypt foci in rats by natural compounds, caffeine, quercetin and morin. Oncol Rep, 6, 1333-40.
46. Verma AK, Jonson JA, Gould MN, Tanner TM (1988). Inhibition of 7,12- dimethylbenz(a)anthracene and nnitrosomethylurea-induced rat mammary gland by dietary flavonol quercetin. Cancer Res, 48, 5754-8.
47. Wang HK (1998). Plant-derived anticancer agents currently in clinical use or clinical trials. The Investigation Drugs Journal, 1, 92-102.
48. Warren BS, Slaga TJ (1993). Mechanisms of inhibition of tumour progression. Basic Life Sci, 61, 279-89.
49. Zhao J, Wang J, Chen Y, Agarwal R (1999). Anti-tumorpromoting activity of a polyphenolic fraction isolates from grape seeds in the mouse skin two stage initiation-promotion protocol and identification of procyanidin B5-30-gallate as the most effective antioxidant constituent. Carcinogenesis, 20, 1737-45.